The first breath-actuated Inhaler “Seroflo Synchrobreathe”

12 January 2019 Author :  

The first breath-actuated Inhaler “Seroflo Synchrobreathe” was launched in Iran between 14th to 16th of Azar 1397 in Kish in order to understand the advantages of this devise in comparison with other available devices in the market. This event was held with outstanding doctors in respiratory field from different parts of Iran.

The first breath-actuated Inhaler “Seroflo Synchrobreathe” was launched in Iran between 14th to 16th of Azar 1397 in Kish in order to understand the advantages of this devise in comparison with other available devices in the market. This event was held with outstanding doctors in respiratory field from different parts of Iran.

We are very proud to mention that Dr. Naghshin, Dr. Ghodrati and Dr. Eslami attended this event as our speakers to talk about the importance of Inhaler devices in managing pulmonary diseases and their impacts on patient compliance.

Seroflo Synchrobreathe is Cipla’s new product containing Salmeterol plus Fluticasone, which is available in two different strengths of 125 and 250 micrograms in drugstores all over the country.

    • 1stFloor,No.15,Padidar Alley,Africa Blvd.
    • Tel: +98 2188197145
    • Fax:+98 2188197153
    • Email: This email address is being protected from spambots. You need JavaScript enabled to view it.

Follow us on:

We use cookies to improve our website. By continuing to use this website, you are giving consent to cookies being used. Cookie policy. I accept cookies from this site. Agree